Ocrelizumab in the treatment of multiple sclerosis: real-world clinical practice experience in the Yaroslavl region

Authors
Category Primary study
JournalNevrol. Neiropsikhiatr. Psikhosomat.
Year 2026
This article has no abstract
Epistemonikos ID: 3d41cde3b49251ab91c3ed4e43bbc240d74d3927
First added on: Mar 14, 2026